Dania Al Jabri, MD
NPI 1174256622 · Research Study Specialist · Augusta, GA
Enrolled with Medicare as Order and Referring Only - Internal Medicine · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Dania Al Jabri, MD is a Research Study Specialist provider in Augusta, GA (NPI 1174256622).
Provider details
- NPI number
- 1174256622
- Entity type
- Individual
- Primary specialty
- Research Study SpecialistOther Service Providers
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure33% of score
3 yrs in NPPES registry
- Profile completeness33% of score
83% of core fields populated
- Practice footprint20% of score
1 documented practice location
- Open Payments transparency13% of score
Has Open Payments disclosures (2024)
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 4 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Atorvastatin Calcium | 28 | 15 |
| Losartan Potassium | 14 | — |
| Amlodipine Besylate | 13 | — |
| Hydrochlorothiazide | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$15 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2022-07-01
- Last updated
- 2022-07-01
- Certified
- 2022-07-01
Frequently asked questions
- What is Dania Al Jabri's NPI number?
- Dania Al Jabri's National Provider Identifier (NPI) is 1174256622, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Dania Al Jabri's specialty?
- Dania Al Jabri is listed in the NPPES registry with a primary specialty of Research Study Specialist (Other Service Providers).
- Where is Dania Al Jabri located?
- Dania Al Jabri's practice location on file with NPPES is 1120 15th St, Augusta, GA 30912-0004.
- What is Dania Al Jabri's phone number?
- The practice phone number listed in the NPPES registry for Dania Al Jabri is (860) 328-8970.
- Does Dania Al Jabri accept Medicare?
- Dania Al Jabri is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Dania Al Jabri's NPI active?
- Yes — Dania Al Jabri's NPI (1174256622) is active in the NPPES registry as of the last update on 2022-07-01.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.